Total Payments
$12,492
2024 Payments
$351.49
Companies
65
Transactions
868
Medicare Patients
4,682
Medicare Billing
$764,810
Payment Breakdown by Category
Food & Beverage$11,406 (91.3%)
Education$723.28 (5.8%)
Other$212.19 (1.7%)
Consulting$150.00 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,406 | 845 | 91.3% |
| Education | $723.28 | 10 | 5.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $212.19 | 12 | 1.7% |
| Consulting Fee | $150.00 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $1,293 | 111 | $0 (2021) |
| AbbVie Inc. | $1,183 | 109 | $0 (2023) |
| Biogen, Inc. | $1,181 | 75 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $951.35 | 26 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $924.94 | 58 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $531.77 | 33 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $479.39 | 38 | $0 (2023) |
| PFIZER INC. | $442.03 | 40 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $382.36 | 42 | $0 (2022) |
| Sunovion Pharmaceuticals Inc. | $331.67 | 31 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $351.49 | 6 | Alexion Pharmaceuticals, Inc. ($259.32) |
| 2023 | $2,705 | 155 | AbbVie Inc. ($507.51) |
| 2022 | $1,729 | 138 | ABBVIE INC. ($473.90) |
| 2021 | $1,040 | 92 | Allergan, Inc. ($392.42) |
| 2020 | $1,781 | 138 | Allergan, Inc. ($546.16) |
| 2019 | $1,563 | 111 | Supernus Pharmaceuticals, Inc. ($249.93) |
| 2018 | $1,865 | 123 | Biogen, Inc. ($412.16) |
| 2017 | $1,458 | 105 | Biogen, Inc. ($403.32) |
All Payment Transactions
868 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/12/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $77.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/21/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $100.00 | General |
| Category: Rare Disease | ||||||
| 05/16/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: NEUROLOGY | ||||||
| 04/15/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $100.00 | General |
| Category: Rare Disease | ||||||
| 04/15/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Education | In-kind items and services | $50.00 | General |
| Category: Rare Disease | ||||||
| 01/31/2024 | Alexion Pharmaceuticals, Inc. | SOLIRIS (Biological), ULTOMIRIS | Education | In-kind items and services | $9.32 | General |
| Category: Rare Disease | ||||||
| 11/29/2023 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Neuromodulation | ||||||
| 10/12/2023 | Alexion Pharmaceuticals, Inc. | — | Education | In-kind items and services | $100.00 | General |
| 09/29/2023 | Abbott Laboratories | INFINITY (Device) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Neuromodulation | ||||||
| 09/28/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: PAIN | ||||||
| 09/27/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.49 | General |
| Category: Neuroscience | ||||||
| 09/26/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: PAIN | ||||||
| 09/25/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: NEUROSCIENCE | ||||||
| 09/20/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: Neurology | ||||||
| 09/19/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $23.71 | General |
| 09/19/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $6.94 | General |
| Category: PAIN | ||||||
| 09/13/2023 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: PAIN | ||||||
| 09/13/2023 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: CNS | ||||||
| 09/12/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $21.17 | General |
| Category: Neurology | ||||||
| 09/12/2023 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: Neurology | ||||||
| 09/12/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $4.75 | General |
| Category: Central Nervous System | ||||||
| 09/11/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Central Nervous System | ||||||
| 09/06/2023 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $23.47 | General |
| Category: Neurology | ||||||
| 08/31/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Central Nervous System | ||||||
| 08/30/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $6.02 | General |
| Category: Central Nervous System | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,111 | 2,381 | $367,281 | $185,267 |
| 2022 | 13 | 1,118 | 2,479 | $378,845 | $181,304 |
| 2021 | 11 | 1,178 | 2,591 | $407,986 | $201,646 |
| 2020 | 15 | 1,275 | 2,840 | $404,625 | $196,593 |
Total Patients
4,682
Total Services
10,291
Medicare Billing
$764,810
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 244 | 632 | $94,168 | $56,119 | 59.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 162 | 858 | $89,232 | $50,964 | 57.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 235 | 249 | $72,459 | $31,583 | 43.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 153 | 224 | $42,784 | $18,962 | 44.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 105 | 114 | $17,556 | $9,670 | 55.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 69 | 69 | $17,043 | $7,189 | 42.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 75 | $10,050 | $3,458 | 34.4% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Facility | 2023 | 12 | 61 | $12,463 | $2,862 | 23.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 44 | 58 | $5,336 | $2,402 | 45.0% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 14 | 15 | $3,915 | $1,345 | 34.3% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 12 | 13 | $1,183 | $372.96 | 31.5% |
| 96137 | Administration of psychological or neuropsychological test, each additional 30 minutes | Office | 2023 | 12 | 13 | $1,092 | $341.52 | 31.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 234 | 714 | $106,386 | $54,607 | 51.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 155 | 830 | $86,320 | $44,009 | 51.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 208 | 222 | $64,602 | $31,193 | 48.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 186 | 311 | $59,401 | $24,701 | 41.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 105 | 115 | $17,710 | $8,944 | 50.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 60 | 60 | $14,820 | $6,021 | 40.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 87 | $11,658 | $4,847 | 41.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 40 | 62 | $5,704 | $2,639 | 46.3% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2022 | 19 | 19 | $4,959 | $1,696 | 34.2% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Facility | 2022 | 11 | 19 | $4,427 | $1,578 | 35.6% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2022 | 14 | 14 | $1,274 | $458.48 | 36.0% |
| 96137 | Administration of psychological or neuropsychological test, each additional 30 minutes | Office | 2022 | 14 | 14 | $1,176 | $411.06 | 35.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 12 | 12 | $408.00 | $201.28 | 49.3% |
About Dr. Niranjan Siva, MD
Dr. Niranjan Siva, MD is a Clinical Neurophysiology healthcare provider based in Paducah, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154330157.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Niranjan Siva, MD has received a total of $12,492 in payments from pharmaceutical and medical device companies, with $351.49 received in 2024. These payments were reported across 868 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($11,406).
As a Medicare-enrolled provider, Siva has provided services to 4,682 Medicare beneficiaries, totaling 10,291 services with total Medicare billing of $764,810. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Clinical Neurophysiology
- Other Specialties Neurology
- Location Paducah, KY
- Active Since 08/07/2006
- Last Updated 04/20/2016
- Taxonomy Code 2084N0600X
- Entity Type Individual
- NPI Number 1154330157
Products in Payments
- BOTOX (Biological) $982.62
- TECFIDERA (Drug) $841.17
- OXTELLAR XR (Drug) $811.84
- UBRELVY (Drug) $754.79
- NURTEC ODT (Drug) $702.89
- NUEDEXTA (Drug) $442.72
- ACTHAR (Biological) $362.37
- APTIOM (Drug) $345.85
- ULTOMIRIS (Biological) $342.63
- QULIPTA (Drug) $320.72
- Aimovig (Biological) $295.57
- ZEPOSIA (Drug) $281.38
- NUPLAZID (Drug) $272.86
- Gamunex-C (Biological) $256.30
- TYSABRI (Biological) $215.15
- NAMZARIC (Drug) $171.79
- VYEPTI (Biological) $156.62
- AMPYRA (Drug) $155.20
- EMGALITY (Drug) $153.73
- AUSTEDO (Drug) $153.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.